StockNoteStockNote
2/9 Pharmaceutical Joint Stock Company (NDP) was established in 1976. In 2001, the company equitized and operated in the form of a joint stock company. The company's main production activities are the production and trading of pharmaceuticals and medicinal materials. The company's head office and factory are located in Ho Chi Minh City. The area of business activities throughout all provinces and cities across the country such as the Mekong Region, the Southeast, the Central, the Northern, the Central Highlands and Cambodia. On April 9, 2013, NDP was officially traded on the UPCOM market.
NDP currently has a market capitalization of roughly VND 211 billion, placing it in the small-cap group on the Vietnamese stock market. Its current P/E of 11,2x is 23% below its own 6-year average (14,5x), suggesting the stock is trading cheaper than its historical norm. P/B stands at 0,8x, 33% below its multi-year average of 1,2x. Return on equity (ROE) is at 8,6%, up from 7,3% the year before. Its debt-to-equity ratio of 0x is low, reflecting a conservative capital structure. In 2025, revenue grew 18% year-on-year while after-tax profit grew 24%.
This note is generated automatically from the stock's real financial data, for reference only — not investment advice.
Unit: VND billion. Growth (%) vs. previous period.
Unit: VND billion. Year-end values; current year uses latest session.
Unit: x. Financial debt over shareholders' equity.
Data aggregated from cafef.vn and VNDirect, for reference only, not investment advice.